“An amendment proposed by Sens. Herb Kohl (D-Wis.) and Dick Durbin (D-Ill.) would prohibit drug companies from mining prescription information for marketing purposes.
The legislation aims to stop “vexatious and harassing sales practices” but it will not regulate the use of data for quality, research and payment purposes, according to language in the amendment. Information could still be used for marketing provided it does not contain individually identifying pieces of data, according to the senators’ proposal.”
Article
Jean DerGurahian, Modern Healthcare, 11 December 2009
